PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development
Proteolysis Targeting Chimera (PROTACs) are a brand-new concept of therapeutics that use the ubiquitin-proteasome system for selective degradation of disease-related proteins. Like other therapeutics, PROTACs function by recruiting a protein target and a ubiquitin ligase that leads to the degradati...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
German Journal of Pharmaceuticals and Biomaterials
2025-01-01
|
| Serie: | German Journal of Pharmaceuticals and Biomaterials |
| Soggetti: | |
| Accesso online: | https://gjpb.de/index.php/gjpb/article/view/154 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|